New hope for kids with rare swelling disorder: early access drug offered
NCT ID NCT07216378
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This program provides early access to an investigational drug called sebetralstat for children aged 2 to 11 with hereditary angioedema (HAE), a condition causing sudden, painful swelling. The drug is taken at the start of an attack to reduce symptoms. It is available to children who have previously been in a sebetralstat study or are new to the drug, if their doctor believes it may help.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
KalVista Investigative Site
AVAILABLEEvansville, Indiana, 47715, United States
-
KalVista Investigative Site
AVAILABLEWheaton, Maryland, 20902, United States
-
KalVista Investigative Site
AVAILABLESt Louis, Missouri, 63110, United States
-
KalVista Investigative Site
AVAILABLESan Antonio, Texas, 78229, United States